Cargando…
Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043624/ https://www.ncbi.nlm.nih.gov/pubmed/24926385 http://dx.doi.org/10.3892/etm.2014.1672 |
Ejemplares similares
-
Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas
por: YUE, YUAN, et al.
Publicado: (2013) -
Retracted: Downregulation of ADAM10 Expression Inhibits Metastasis and Invasiveness of Human Hepatocellular Carcinoma HepG2 Cells
por: BioMed Research International,
Publicado: (2014) -
Synergistic effects of co-expression plasmid-based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo
por: Liu, Songyang, et al.
Publicado: (2022) -
miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma
por: Liu, Yahui, et al.
Publicado: (2022) -
Downregulation of ADAM10 Expression Inhibits Metastasis and Invasiveness of Human Hepatocellular Carcinoma HepG2 Cells
por: Yue, Yuan, et al.
Publicado: (2013)